Kineta (Reverse Merger With Yumanity Therapeutics) jobs and careers
About Kineta (Reverse Merger With Yumanity Therapeutics)
Yumanity Therapeutics is a biotechnology company that transforms drug discovery for diseases caused by protein misfolding.
Founded in 2014 by Susan Lindquist and Tony Coles.
- Founded
- 2014
- Employees
- 11 to 50
- Total funding
- $137.4M
Leadership
The top of Kineta (Reverse Merger With Yumanity Therapeutics)'s org chart, with how many people report into each leader.
KL
Kurt Lustig
Director, Translational Development
1 report
CM
Charles Magness
Co-founder
TL
Thu le
Controller
YO
Yulia Ovechkina
Associate Director, Immuno-oncology
Board
MC
Michael A. Curran
Advisor
MC
Myriam Chalabi
Advisor
EY
Evan Y. Yu
Advisor
MF
Marion R. Foote
Director
LC
Lisa Coussens
Advisor
PL
Patricia LoRusso
Advisor
Jobs at Kineta (Reverse Merger With Yumanity Therapeutics)
No open positions right now. Explore more companies on TheJobsMap.